Question to the Department for Business, Innovation, Science and Trade:

To ask the Secretary of State for Business, Innovation, Science and Trade, what progress has been made towards the Government's target of reducing the use of dogs in dedicated pharmacokinetic studies by at least 35% by 2030; and how much funding has been allocated to develop non-animal methods to replace the use of dogs.

The Replacing Animals in Science strategy includes a target to reduce the use of dogs in dedicated pharmacokinetic studies for human medicines by at least 35% by 2030, where scientifically justified and supported by validated alternatives. Progress is being supported through work with regulators, industry and research partners to develop, validate and increase uptake of alternative methods. The Government has allocated up to £2 million through Innovate UK to support the development of human-relevant approaches to pharmacokinetic and safety testing, including projects aimed at reducing reliance on dogs in medicines development.